Chimeric Therapeutics Ltd. (AU:CHM) has released an update. Chimeric Therapeutics, a leading Australian cell therapy company, has appointed Dr.

Researchers at the University of Basel have developed CAR T-cells that target glioblastoma, a notoriously aggressive brain ...

*仅供医学专业人士阅读参考APOE4是阿尔茨海默病（AD）的最强遗传风险因素，降低AD发病年龄，促进AD的典型病理，包括β-淀粉样蛋白（Aβ）和过度磷酸化的tau蛋白（p-tau）沉积。APOE4在AD发病机制中的作用十分复杂，仍没有被完全揭示。星形 ...

Chimeric Therapeutics Ltd. (AU:CHM) has released an update. Chimeric Therapeutics made significant strides in its cell therapy programs, enrolling the first patient in its CHM CDH17 Phase 1/2 ...

Chimeric Therapeutics Ltd. (AU:CHM) has released an update. Chimeric Therapeutics, a leader in cell therapy, has announced a ...

Chimeric Therapeutics Ltd. (AU:CHM) has released an update. Chimeric Therapeutics Ltd. has announced the issuance of nearly 70 million fully paid ordinary shares for quotation on the Australian ...

Researchers have developed an innovative CAR T-cell therapy to combat glioblastoma, the most common malignant brain tumor in ...

通过VOS viewer软件进行关键词共现分析得出，多黏菌素B的抗菌机制、微生物耐药性机制与检测、多黏菌素B的药代动力学、多黏菌素B的临床应用尤其是脓毒症的临床应用为近年研究热点。WOS ...

The Filipino-born artist takes a journey through primordial mud, chimeric worlds, and suppressed psychic demons to honor ...

《中时新闻网》前身为《中时电子报》，于1995年创立，是全台第一家且歷史最悠久的网路媒体，开启新闻数位时代。近来以最具影响力的政治新闻引领先驱外，首创娱乐、生活、社会专题式新闻报导，带起同业间仿效风潮；精辟的言论、财经、国际、两岸、军事、体育、网推频道，网罗忠实读者群；新型态的汽车、房屋、玩食、科技频道，成为阅听眾休閒必看选择。视觉影音上，结合中天新闻直播、FB直播、中时新闻网APP等平台的精彩内 ...

Cancer cell therapy house Chimeric Therapeutics is going to the well for a much-needed capital raising to fund its clinical programs. Read more in our health wrap. Chimeric shares have been ...